Navigation Links
Takeda Cares Day Raises $63,700
Date:9/20/2013

DEERFIELD, Ill., Sept. 20, 2013 /PRNewswire/ -- Takeda, a top 15 global pharmaceutical company, will raise money for local organizations today when employees participate in their third annual Takeda Cares Day event on the company's Deerfield campus.

More than 600 employees will run or walk a 5K course on the company's campus. Takeda will donate $100 for each employee who participates in the event to one of three community organizations that the participating employee has pre-selected. An estimated $63,700 will be raised. The event will also host speakers from the local community organizations.   

Takeda is a company that strives toward better health for people worldwide through leading innovation in medicine. This pursuit begins when employees participate in a culture of health through events like Takeda Cares Day. Further, the event recognizes employees' commitment to making a difference in the community through Takeda's corporate giving programs, many of which align with the company's three focus areas – health, science and community vitality.

Donation Recipients
In its third year, the event was created to advance Takeda's philanthropic commitment to the Chicagoland area and to promote employee camaraderie. This year's beneficiaries dedicate their time to the following causes:

  • HealthReach - A free medical clinic that provides a patient-centered medical home to 5,000 of the uninsured, underserved residents of Lake County, Ill.
  • Junior Achievement of Chicago - An educational nonprofit bringing financial literacy, work readiness and entrepreneurship programs into classrooms from kindergarten through high school.
  • R&D (STEM) Learning Exchange - Brings interested learners together with organizations that can provide unique opportunities in science, technology, engineering and math (STEM) education.

"By supporting HealthReach, Takeda is making an impact and changing the lives of the medically uninsured, providing them with high quality care where they are treated with dignity and respect," said Nancy Bock, Executive Director of HealthReach. "HealthReach is grateful for the support Takeda is providing toward our mission and the people we serve every day."

About Takeda in the Chicagoland Area
As a science and evidence-based company with a strong presence in Deerfield, Ill., Takeda is committed to contributing to the health of people worldwide and supporting the community and the environment. Takeda Pharmaceuticals U.S.A., Inc., and Takeda Development Center Americas, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market metabolic, gout, gastroenterology, and central nervous system treatments and seek to bring innovative products to patients. To learn more about these Takeda companies, visit www.takeda.us.

Contacts:

Kara Hoeger
Takeda Pharmaceuticals U.S.A, Inc.
(224) 554-1277
kara.hoeger@takeda.com


'/>"/>
SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil
2. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
3. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
4. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
5. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
6. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
7. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
8. Takeda and Resolve Therapeutics Enter Autoimmune Partnership
9. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
10. Takeda presenta la richiesta di autorizzazione allimmissione in commercio nellUnione Europea per Vedolizumab nella colite ulcerosa moderata-grave e nella malattia di Crohn
11. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 /PRNewswire/ ... Diabetes Tomorrow,s Leaders Scholarship is any indication, the future ... today online at www.diabetesscholars.org by the Diabetes ... stand in the way of academic and community service ... scholarship program since 2012, and continues to advocate for ...
(Date:6/23/2016)... -- Revolutionary technology includes multi-speaker listening to ... leaders in advanced audiology and hearing aid technology, has ... the world,s first internet connected hearing aid that opens ...      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) , ... firsts,: , TwinLink™ - the first dual ...
Breaking Medicine Technology:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... for mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... solutions to the network of the Tennessee Counseling Association, adding exclusive benefits and ...
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified ... be personalized through a fitness app. The fitness app plans to fix the two major ... only offer a one size fits all type program , They don’t eliminate ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):